Home HealthTopics Health Centers Reference Library Research
Join us on Facebook Join us on Facebook Share on Facebook

Colon Cancer

Colon cancer patient using vectibix



What is their survival rate after eleven months of chemo and no other options but vextibix.


It is difficult to answer without knowing more details. But in patients who failed multiple therapies and got vectibix only, average survival is less than 6 months.

For more information:

Go to the Colon Cancer health topic, where you can:

Response by:

Malek  Safa, MD Malek Safa, MD
Assistant Professor of Medicine
College of Medicine
University of Cincinnati